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Summary 
LEW (RT1 l) rats were immunized with peptides corresponding to the c~ helical region of the 
oll domain (peptide 1), the fl sheet of the oe2 domain (peptide 2), and the a  helical region of 
the c~2 domain (peptide 3) of the RT1-A avl classical class I molecule of the DA (RT1 'vl) strain. 
The immunizations were without carriers, and the objective was to prime to indirect allorecognition 
without influencing direct recognition of the RT1-A  avl molecule. The LEW rats mounted strong 
primary and secondary antibody responses to peptides 1 and 3, but only weak secondary responses 
to  peptide 2.  None of the antipeptide antibodies  crossreacted with intact  RT1-A  a~l class I 
molecules. The immunizations also resulted in LEW antigen-presenting  cell-dependent, CD4 + 
T cell proliferative responses, which were very strong against peptide 1 and weakest against peptide 
2. LEW rats immunized with peptides  1 or 3, but most effectively with both peptides  1 and 
3 together, showed accelerated rejection of DA skin allografts. This effect was not observed in 
LEW rats immunized with peptide 2. In response to the DA skin aUograft, the peptide-immunized 
LEW rats showed markedly accelerated kinetics of antibody production to the intact RT1-A ~1 
molecule. These data demonstrate that indirect  allorecognition can play an important role in 
allograft rejection and have important implications for understanding allograft rejection and its 
regulation. 
T 
he TCR normally recognizes foreign antigens as pep- 
tide fragments in association with self-class I and II MHC 
molecules. The major exception to this rule occurs in tissue 
transplantation  and in in vitro models of alloreactivity. Here, 
the responding T cells are able to recognize the foreign MHC 
antigens as intact molecules on the surface of the allogeneic 
cells. The enigmas of direct recognition and aUoaggression 
have been the subject of much research and speculation (1-5). 
However, it is clear that the precursor frequency for direct 
allorecognition is extremely high, with estimates of 1-10% 
of T cells in any individual being able to respond in prolifera- 
tive responses to a foreign MHC (3). There is also little doubt 
that the direct pathway of allorecognition provides a strong 
stimulus both to proliferative responses for possible delayed- 
type hypersensitivity  (DTH) 1 reactions, and for cytotoxic T 
cell responses to the foreign cells of the graft. 
Recognition of the foreign MHC and other antigens of 
t Abbreviations  used in thispaper: DTH, delayed-type hypersensitivity; NRS, 
normal rat serum; RAR,  rabbit F(ab')2 anti-rat F(ab')2. 
the graft as conventional exogenous antigens, i.e., processed 
and presented as peptides in class II MHC molecules of re- 
cipient APC under the normal rules of MHC restriction (6), 
has received relatively little attention. This pathway is best 
termed "indirect allorecognition."  Whether or not indirect 
allorecognition plays a significant role in allograft rejection 
is of fundamental importance in transplantation,  since the 
requirements for activation  and the mechanisms of regula- 
tion will be quite different from those for indirect recogni- 
tion, as will be discussed later. Thus, the interpretation of 
transplantation  phenomena and attempts at tolerance induc- 
tion will be markedly influenced if both of these quite dis- 
tinct pathways of T cell recognition play a significant role 
in rejection. 
The possibility that processing of graft antigens by recip- 
ient APC might be important in allograft rejection was sug- 
gested a decade ago (7-9). However, the only experiments 
to specifically address this issue in transplantation  have been 
those by Sherwood et al. (11). They were able to transfer 
specific sensitization for skin allograft rejection to naive mice 
by the transfer of T cell-depleted peritoneal and spleen cells 
from syngeneic mice injected 3 d previously with donor spleen 
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recognition in the second hosts, Sherwood et al. (11) demon- 
strated undegraded donor class II MHC antigens in the trails- 
ferred inoculum, so that priming to direct allorecognition 
in the secondary hosts could not be entirely ~.cluded. 
In a previous study (10), we immunized LEW rats with 
isolated, denatured RT1-A class I and RT1-Bot and RT1-BB 
dass II MHC chains of the DA strain, with a view to priming 
to indirect allorecognition without influencing direct recog- 
nition. The use of synthetic peptides corresponding to short 
segments of the polymorphic regions of donor MHC an- 
tigens is a much better approach, since there is virtually no 
risk of priming to direct recognition, and the system lends 
itself more easily to further analysis. However, defining poly- 
morphic MHC peptides able to prime allogeneic T  cells is 
problematic.  More  importantly,  MHC  peptides  able  to 
influence allografr rejection have not previously been reported. 
Here we describe peptides from the RT1-A dass I MHC mol- 
ecule of the DA strain that can cause second-set rejection of 
DA skin grafts in LEW rats, and that can result in T helper 
or "carrier" type priming for antibody responses  to the in- 
tact dass I molecule. 
Materials and Methods 
Rats 
Inbred DA (KTI  'vl) and LEW (R.T11) male rats were purchased 
from Harlan Olac (Bicester, Oxon, UK). 
Peptides 
Three 22-24-amino  acid peptides were chosen to correspond 
to the most variable regions of classical class I MHC molecules 
(12), and the amino add sequence  was that deduced  from the cDNA 
sequence of the RT1-A  *vl classical  dass I gene of the rat (13). Pep- 
tides 1 and 3 correspond to the e~ helical regions of the first and 
second domains, respectively, and peptide 2 to the B sheet of the 
second domain, assuming a structure similar to HLA-A2 (14). The 
actual sequences, numbering from the beginning of the first do- 
main, were: peptide 1 (57) Pro-Glu-Tyr-Trp-Glu-Gln-Gln-Thr-Arg- 
Ile'Ala'Lys'Glu'Trp'Glu'Gh'Ile'Tyr'Arg'Val'Asp'Leu'Arg'Thr;  pep- 
tide 2 (94) Thr-Ile-Gh-Glu-Met-Tyr-Gly-Cys-Asp-Val-Gly-Ser-Asp- 
Gly-Ser-Leu-Leu-Arg-Gly-Tyr-Arg-Gh-Asp-Aia;  peptide 3 (143) Thr- 
Arg-Asn-Lys-Trp-Gh-Arg-Ala-Arg-Tyr-Ala-Gh-Arg-Leu-Arg-Ala- 
Tyr-Leu-Glu-Gly-Thr-Cys. 
An irrelevant 20-amino acid peptide corresponding to amino 
adds 60-79 of the c~ helical region of the KT1-D~' class II MHC 
(15) molecule was used as a control. All peptides were purchased 
fxom Cambridge Research  Biochemicals  (Cambridge, UK) and were 
further purified by desalting on G10 columns (Pharmacia, Upp- 
sala, Sweden), freeze drying, and reconstituting in 0.15 M NaC1 
at 1 mg/ml as stock solutions. Peptides were always used as free 
molecuhs, without any carriers, 
Peptide Immunization 
LEW rats received  50/~g of free peptide in CFA subcutaneously 
into each hind footpad (100/~g of  peptide per rat) and were boosted 
4 wk later with the same dose of peptide to the same site in IFA. 
The only exception to this schedule  was in rats being simultane- 
ously immunized with peprides 1 and 3, in which case 100/~g of 
peptide 1 was given to the left footpad and 100/xg of peptide 3 
to the right footpad. 
mAbs 
The BMAC-5 hybridoma cell line secreting mouse IgG1 anti- 
body to rat macrophages has previously been described in detail 
(16). The cell lines secreting the W3/25 antibody to rat CD4 (17), 
and the MRC OX8 antibody to rat CD8 (18) and the MRC OX6 
antibody to rat RT1-B class II MHC antigen (19), were kind gifts 
of Professor A.F. W'tlliams  (MRC Cellular Immunology Unit, Ox- 
ford, UK). These antibodies were used as immune ascites partially 
purified by ion exchange chromatography (20). 
The MR.C OX35 antibody (21) to a nonoverlapping  determinant 
(with regard to W3/25) of rat CD4 and the MRC OX12 antibody 
(22) to the rat Ig g light chain were purchased from Serotec (Bices- 
ter, Oxon,  UK). 
Conventional Antibodies 
Immunoadsorbent purified rabbit F(ab')~ anti-rat F(ab')2 (PAR) 
was prepared as previously described in detail (23) and iodinated 
using the chloramine T method. 
Cell Preparations 
Unseparated Lymph Node Cells.  Popliteal, cervical, para-aortic, 
and mesenteric  lymph nodes were removed  aseptically  and dispersed 
into single call suspensions in Hepes-buffered  RPMI 1640 (Flow 
Laboratories, Irvine,  Scotland) containing  1%  heat-inactivated 
normal rat serum (NR.S). The cell preparation was performed at 
4~  unless it was to be depleted of  macrophages, when the proce- 
dure was carried out at room temperature. After washing, the calls 
were resuspended at 2 x  106 ceils/ml in RPMI 1640 supplemented 
with 2 mM glutamine, 5  x  10-s M 2-ME, 100 U/ml penicillin, 
100/~g/ml streptomycin, and 5% heat-inactivated NRS (Gibco, 
Paisley, Scotland), hereafter referred to as culture medium. 
Depletion of  Adherent Cells.  Cell suspensions  in Hepes-buffered 
RPMI 1640 with 1% NRS were applied to sterile Sephadex G-10 
(Pharmacia, Milton Keynes,  UK) cohmns previously  equilibrated 
in this buffer at 37~  After 30 min at 37~  the cells were duted 
with a one-column volume of Hepes buffer, washed once, and 
resuspended in culture medium at 2  x  106 cells/ml. 
Separation of CD4 + and CD8 + Cell Subsets.  Cell suspensions 
were first depleted of adherent cells as described in the preceding 
section. All subsequent procedures were carried out at 4~  For 
the  "CD8 +''  preparation,  the  MR.C OX12, MKC  OX35, 
W3/25, MRC OX6, and BMAC-5 antibodies were added to coat 
the B cells, CD4 § cells, and any residual macrophalges. For the 
"CD4 +" preparation, the MRC OX12, MRC OXS, MRC OX6, 
and BMAC-5 antibodies were added to coat the B cells, CD8 + 
cells, and any residual macrophages. These reactions  contained cells 
at 5  x  107/ml and antibodies at saturating concentrations. The 
preparations were incubated on ice for 30 min and then washed 
twice  by  centrifugation.  The  cells were resuspended at  10  s 
cells/ml, and sheep anti-mouse IgG-couphd  Dynabeads (Dynal 
[UK] Ltd., Wirral, Merseyside)  were added to the cell preparation 
at a ratio of 10 beads per cell. This was incubated at 4~  for 60 
min with frequent agitation, and the beads were then removed  using 
a magnetic particle  concentrator (Dynal [UK] Ltd.). The cells  were 
washed once and resuspended in culture  medium at  2  x  106 
cells/ml. Purity of the subsets was checked using flow cytometry 
with directly fluoresceinated  MRC OX8 and W3/25 antibodies, 
and was always >98%. 
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room temperature from the spleens of normal LEW rats, and con- 
taminating  RBC were removed by incubating  in  Tris-buffered 
NH4C1 (24). The ceUs were exposed to 1,500 tad of irradiation 
from a 137Cs source using a gamma cell 1000 apparatus (Isomedix 
Inc., Whippany, NJ) at 100% dose for 1.2 rain. The cells were then 
washed once and ~suspended at 2  x  106 calls/m1  in cttlture medium. 
Cell Proliferation  Assays.  2  x  10  s cells were incubated in round- 
bottomed, 96-well tissue  culture plates (Sterilin, Feltham, England) 
in 200-/~1 volumes of culture medium. Incubations were at 37~ 
in 5% COz in air. To some cultures, 10  s irradiated APC were 
added. Cultures were stimulated with the RT1-A  ~vl peptides and 
irrelevant peptide, as well as Con A (Pharmacia) at 10/~g/ml as 
a positive control. 24 h before harvesting, 1/zCi of fH]thymidine 
in 20/~1 of culture medium was added to each well. 
Cell-bound radioactivity was measured by placing dried falters 
in Optiscint Hisafe scintillation fluid (LKB, Milton Keynes, UK) 
and counting in a rackbeta 11 liquid scintillation counter (LKB, 
Bromma, Sweden). 
Indirect Radioactive Binding  Assays 
Plate Assay.for Alloantibedies to the Peptides.  ALl procedures were 
at 4~  or on ice. 25 #1 of peptide at 100/~g/ml in 0.15 M NaC1 
was added in triplicate  to wells  in a 96-well polyvinyl  chloride (PVC) 
microtiter plate (Dynatech Ltd., Billingshurst, Sussex). The plate 
was then washed three times in 0.1% BSA/PBS. 25/~1 of serum 
diluted in 0.5% BSA/PBS was added and the plate incubated for 
60 rain. The serum was removed, and the plates were washed as 
above. 50/~1 of l~I-labeled RAR in 0.5% BSA/PBS (m300,000 
cpm/well) was added and the plate was again incubated for 60 rain. 
The iodinated antibody was removed, and the plates were washed 
three times as above. Individual wells were cut out, and the bound 
radioactivity was measured using an ultragamma counter (LKB). 
Tube Binding Assay for Alloantibodies to Whole RT1-A a~l Class I 
Molecules.  This was performed essentially  as described  by Morris 
and Williams (25). All procedures were at 4~  or on ice. Dupli- 
cate 25-/zi aliquots of rat serum diluted in 0.5% BSA/PBS were 
transferred to LP3 tubes (Luckham Ltd., Burgess Hill, Sussex). 25 
/~1 of DA strain RBC at 109/ml in 0.5% BSA/PBS was added as 
targets to each tube, and this was incubated for 1 h. The cells were 
then washed twice in 0.1% BSA/PBS, and 100 #1 of nSI-labeled 
RAR in 0.5%  BSA/PBS (300,000 cpm/tube)  was added to the 
pellet of the second wash. This was resuspended and incubated for 
1 h, and the cells were washed twice as above. The pelht of the 
second wash was resuspended  in 0.5 ml of PBS, transferred to fresh 
LP3 tubes, and the target cell-bound radioactivity was measured 
in the ultragamma counter (LKB). 
Skin  Transplantation 
Full-thickness grafts of abdominal skin, "~2 cm  2 in area, were 
placed on corresponding full-thickness  defects over the dorsolateral 
thoracic wall of recipients. Corner sutures of 4-0 silk were used 
to secure the graft in place, and a dressing of vaseline gauze, dry 
gauze, and ehstic bandage was applied. The dressings  were removed 
at day 6 and the grafts allowed to dry for 4-6 h before assessment. 
Thereafter, they were assessed  daily. The day of  rejection was taken 
as the day on which >90%  full-thickness loss had occurred. 
Results 
Preliminary  Considerations.  As only one classical class I 
MHC sequence  is known in the rat (RT1-A~I), and more 
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specifically since the RT1-A sequence of the LEW strain is 
not known, we synthesized  relatively long peptides from the 
hypervariable regions of RT1-A  avl (12) to ensure that the 
peptides would encompass regions that were polymorphic 
between the DA and LEW strains. For our experimental de- 
sign, peptide length was not of primary importance, as it 
was necessary only that direct recognition would not be trig- 
gered. Whether or not the peptides were further processed 
to smaller fragments was of no consequence from the point 
of view of our experimental objectives.  Indeed, in view of 
recent data on optimal peptide length for class II binding 
(26), one would guess that further processing is likely to have 
occurred. 
Alloantibody  Responses to the Peptides.  The antibody re- 
sponses of LEW rats immunized with the RT1-A  ~vl peptides 
is given in Fig. 1. It can be seen that peptides 1 and 3 induced 
strong primary and secondary alloantibody responses, while 
peptide 2 induced no primary response and only weak sec- 
ondary responses. These antibody responses were of interest 
because provision of T cell help for B ceils requires  recogni- 
tion by the helper T  cell receptor of antigenic peptides on 
the class II molecules of the B ceils (27).  The presence  of 
an antibody response to free peptide therefore suggests that 
the peptide is able to provide helper determinants, i.e., is able 
to interact with LEW class II MHC molecules. An addi- 
tional important point is that antibodies to the peptides might 
interact with the whole class I molecule, and thereby influence 
graft rejection either positively by contributing to graft damage 
(28), or negatively because of  passive enhancement effects (29). 
In fact, antisera to the RT1-A  'vl peptides did not react at all 
with whole RT1-A  avl class 1 molecules, as shown by their 
complete failure to react with DA erythrocytes in binding 
assays (Fig.  2). 
The antibody responses also demonstrate that the regions 
of the  RT1-A  a~l  molecule chosen  for  study were  indeed 
polymorphic between the DA and LEW strains. 
T  Celt Reactivity  to the Peptides.  Confirmation of T  cell 
reactivity to the peptides was obtained by testing the prolifer- 
ative response  of lymph node lymphocytes from peptide- 
immunized LEW rats. Fig. 3 a demonstrates that LEW rats 
immunized with peptide 1 showed strong proliferative re- 
sponses to peptide 1, but not to peptides 2 and 3 or to the 
control peptide. Fig. 3, b and c show that this response  is 
dependent on LEW APC and mediated entirely by CD4 + 
T cells. LEW rats immunized with peptide 2 (Fig. 3, d-f) 
and peptide 3 (Fig.  3, g-i)  shoxved similar but weaker re- 
sponses. Peptide 2 consistently gave the weakest response. The 
absence of proliferation by CD8 + T cells is consistent with 
the general rule that exogenous antigens are recognized by 
CD4 + T  ceils (6). 
The Influence of Peptide Immunization on Skin Graft Rejec- 
tion.  The preceding data demonstrate that indirect recogni- 
tion of the three RT1-A  a~l peptides does occur in the LEW 
strain. However, does it make a significant contribution to 
the effector mechanisms of rejection? This was tested by im- 
munizing LEW rats with the RT1-A  ~1 peptide and seeing 
if this influenced the survival of skin allografts.  The results 
are given in Table 1. In the first series of experiments, slight 40 1  Peptide  1 
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Figure  2,  Crossreactivity  of 
anti-RT1-A ,~1 peptide sen on in- 
tact  RT1-A  ~vl class I molecules. 
Sera taken from LEW rats 4 wk 
after the booster  injection  with 
peptide 1 (f-l), peptide 2 (A), or 
peptide  3  (x),  or from control 
LEW rats given Freunds adjuvant 
only (I)  were tested in binding 
assays on the immunizing  peptide 
(a) or DA RBC  (b).  Antibody 
binding was detected  using l:Sl- 
labeled RAR. cpm refers to lzsI 
RAK bound per assay. 
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Figure  1.  Alloantibody responses to RT1-A"~  peptides in LEW rats. 
LEW rats were immunized with 100/~g  of peptide from the RT1-A  'v~ 
class 1 molecule in CFA and boosted 4 wk later with the same dose of 
peptide in IFA. Peptides were used as free molecules,  without any carriers. 
The rats were bled at 2 wk (m), 4 wk (A), 6 wk (x), and 8 wk (D) 
after the initial injection,  and the sera assayed on tvVC microtiter  plates 
previously coated with immunizing  peptide. Antibody to the peptide was 
detected using 12Sl-labeled  RAR. cpm bound refers to lzsI RAR bound 
to each well. Background  binding to wells without peptide was similar 
for all sera and a representative serum is given (  ). For each peptide, 
time course  studies were performed on three rats, and all three within 
each group gave very similar results. Data from a representative rat from 
each group  are given. 
but significant shortening of skin graft survival was obtained 
in LEW rats immunized with peptides I and 3, but not pep- 
tide 2. In view of the weak effect observed, the entire experi- 
ment was repeated,  and on this occasion a group of LEW 
rats given both peptides I and 3 was included. It can be seen 
that the effect observed  with peptides 1 and 3, although small, 
was reproducible.  Of particular  significance was  the more 
marked shortening of graft survival  seen in the LEW  rats 
given both peptides 1 and 3. It is interesting that the weakest, 
and statistically  insignificant,  effect was seen with peptide 
2, which induced the weakest antibody (Fig.  1) and T  cell 
proliferative  (Fig.  3) responses  in LEW  rats. 
Possible Effector Mechanisms.  Indirect aUorecognition might 
influence graft rejection by two quite distinct mechanisms. 
The first involves a direct effector mechanism,  mediated by 
a DTH-type reaction within the connective tissues of the graft, 
as previously suggested (30). The other involves the provi- 
sion of help for conventional effector mechanisms requiring 
T  cell hdp,  i.e.,  CD8 + cytotoxic T  call generation and al- 
loantibody  production.  CD4 +  T  cells,  primed  to  donor 
MHC peptides,  represent  primed T  helper  cells and could 
amplify or accderate CD8 + cytotoxic T cell or antibody re- 
sponses  to the graft. 
We were in a position to test the effect of priming LEW 
rats to the RT1-A 'vl peptides on the antibody response to 
whole RT1-A avl class I molecules on DA skin grafts. Since 
the B  lymphocytes  specific  for the whole  RT1-A 'vl mole- 
cules would be virgin in the peptide-immunized  rats,  this 
would represent an unusual and interesting example of carrier- 
type priming in antibody responses  (31). The results  were 
similar for rats immunized with peptides 1, 2, or 3, and the 
results for peptide 3-immunized LEW rats are given in Fig. 
4. Fig. 4 a gives the kinetics of the antibody to whole RT1- 
A avl molecules in a typical control LEW rat after grafting 
with DA skin. There was no detectable response at day 7, 
a weak response at day 10,  and a good response at day  14. 
Fig. 4 b gives the kinetics of the response in a typical peptide 
3-immunized rat. It is worth noting (as previously demon- 
strated in Fig. 2) that at the time of grafting, i.e., at 4 wk 
after the booster injection with peptide, and at a time when 
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Figure 3.  T cell proliferative re- 
sponses to  RT1-A  Iv1  peptides  in 
LEW  rats.  LEW  rats  were  im- 
munized with peptide 1 (a-c) pep- 
tide 2 (d-f), and peptide 3 ~-,) ~m 
the RT1-A  "1 class I molectde. 10 d 
after the booster injection, whole 
lymph node cells (a,  d,  and g) 
purified CD4* T cells (b, e, and h) 
or purified  CD8 + T cells (c, f, and 
i) were incubated  with 10 ~tg/ml  of 
peptide 1 ([]), peptide 2 (A), pep- 
tide 3 (x), or no peptide (ll). The 
CD4 +  and CD8 +  T  cell  subsets 
were  incubated  in  the  presence 
(  )  or  absence (  ....  )  of 
added APC. cpm refers to mean of 
triplicate counts of pH]thymidine 
incorporated into the cells. The ex- 
periments with unseparated lymph 
node lymphocytes  were performed 
on four occas/ons and the subset 
studies on  two  occasions, with 
similar results in all cases. A repre- 
sentative study is given. 
the antipeptide response was very strong (refer  to Fig.  1), 
there was absolutely no reaction against the whole RT1-A  "x 
molecule on DA RBC.  At 7 d after skin grafting there was 
a small, but significant, level of antibody against whole RT1- 
A a'l class I molecules.  This was greatly augmented at day 
10, when the peptide-immunized rat had a very strong re- 
sponse to DA RBC, while the control rat had only a weak 
response. Fig. 4, c and d show the individual titrations against 
whole RT1-A "~1 class I molecules  at day 10 after  DA skin 
grafting  in  five  control  LEW  rats  and  all  six  peptide 
3-immunized LEW rats of series 2 (Table  1). It can be seen 
that all peptide 3-immunized rats had greatly increased ki- 
netics  of the antibody response to whole RT1-A  a~l class I 
molecules. 
1525  Fangmann  et al. 
Discu~ion 
The immune response to allogeneic MHC molecules is 
unique in offering two quite distinct pathways of T cell rec- 
ognition. Since the activation requirements and the regula- 
tory control of the direct and indirect pathways will be quite 
different, our demonstration that the indirect pathway can 
play an important role in allograft rejection is potentially of 
fundamental importance. 
With regard to activation, the direct pathway of allorecog- 
nition is heavily dependent on allogeneic dendritic cells, at 
least in vitro (32). Whether or not interstitial dendritic cells 
(33) play the major role in stimulating direct allorecognition 
after organ transplantation is not certain, but the dramatic 
effects of their removal (9, 34) suggest that this is the case, Table  1.  Survival of DA (gT1"v9 Skin Allografts on LEW (RT19 Recipients Immunized with RT1-A"  Peptides 
Series 1  Series 2 
Skin graft  Skin graft 
Group*  survival*  p value  s  survival*  p value  s 
d  d 
Control  9, 9,  9, 9, 9,  9  9, 9,  9, 9, 9,  9 
10,  10,  10  9,  10,  10 
Peptide 1  7,  8, 8, 9, 9,  9  0.04  7, 8, 8, 8, 9 
Peptide 2  8,  8, 9, 9  NSII  8, 8, 9, 9, 9,  9 
Peptide 3  7, 7, 8, 8, 9,  9  0.01  8, 8, 8, 8, 9,  9 
Peptide 1 
plus Peptide 3  Not done  7,  7,  7,  8, 8,  8 
0.005 
NSII 
0.01 
<0.01 
* LEW rats were immunized  with peptides as described in Materials and Methods, and full thickness allografts of abdominal skin from DA rats 
were placed 4 weeks after the booster injection. Control rats received Freunds adjuvant only. 
* For scoring, rats were presented  in a random fashion, and the assessment was made without knowledge  of the group to which the rat belonged. 
Results were not divulged until all rats in the series of experiments  had rejected their grafts. The end-point of rejection was taken as >90% full- 
thickness graft loss. 
S Pisher's exact test, two tailed, in comparison with the control group. 
lip >0.1. 
at least in come strain combinations in rodents. However, 
because donor antigens are processed and presented by recip- 
ient APC, the precise cellular origin of the donor antigens 
will be of no importance for the indirect pathway. Probably 
the only important factor will be quantity of donor antigen. 
In this regard, class I MHC antigens are likely to be of greater 
importance than class II MHC antigens, as class I antigens 
are much more abundant in the commonly transplanted organs 
(35),  at least in the absence of overt rejection (36). 
The situations in which direct and indirect allorecogni- 
tion are important are likely to differ. T cells involved in di- 
rect recognition have a high precursor frequency and induce 
strong primary immune responses in vitro (3). By contrast, 
T  cells  involved in  indirect  recognition will  have  a  low 
precursor frequency, as for any nominal antigen. Indirect rec- 
ognition might therefore be important only some time after 
exposure to antigens, e.g., in the later stages of primary re- 
jection responses, in chronic rejection, and after previous ex- 
posure to histocompatibility antigens (e.g., previous trans- 
plants,  pregnancies, blood transfusions). 
Direct recognition, however, might be of greatest impor- 
tance in the early stages of the primary acute rejection re- 
sponse.  This is not only because of the high initial T  cell 
precursor frequency, but also because interstitial dendritic cells 
are migratory (33), being replaced by recipient interstitial den- 
dritic cells within 2 wk of transplantation (37).  If no other 
cells in the graft are able to ef~ciently stimulate direct recog- 
nition, this will leave the graft with little or no capacity to 
stimulate direct recognition. The major controversy concerns 
the capacity of class II-positive vascular endothelial cells, a 
permanent component of the graft, to stimulate direct T cell 
recognition (38-40). The relative importance of dendritic cells 
and dass II-positive vascular endothelial cells for stimulating 
direct recognition is unknown, but it is a crucial factor in 
clinical transplantation.  For example, it will determine the 
long-term vulnerability of transplanted human organs to di- 
rect recognition and therefore the relative importance of di- 
rect and indirect recognition in chronic rejection, which is 
now the major immunological problem in clinical transplan- 
tation. 
With regard to regulatory processes,  recent advances in 
our understanding of the physiology of stir-tolerance (e.g., 
reference 41), would suggest that thymic ddetion of T cells 
with spedficity for direct allorecognition of the graft will 
not occur in recipients of organ allografts. This follows from 
the fact that living donor cells, able to present intact donor 
MHC molecules, are not present in the thymus of these pa- 
tients. By contrast, model studies in transgenic mice suggest 
that peripheral exposure to antigens such as OVA can lead 
to thymic deletion of specifically reactive T  ceils (42).  It is 
therefore possible that the systemic release of graft antigens 
might result in thymic tolerances to indirect allorecognition 
(irrespective of its effect on peripheral T cells), as previously 
discussed in detail (43).  Moreover, T  cetl anergy, a regnla- 
tory process consequent on T cell recognition of antigen in 
the absence of essential costimulatory signals (44), is unlikely 
to occur for indirect recognition, because, by definition, the 
presenting cell is a professional recipient APC. 
Elucidating the precise mechanisms whereby indirect rec- 
ognition contributes to the effector mechanisms of rejection 
was not the major objective of this paper.  However, it is in- 
teresting to speculate on the possible mechanisms. There are 
two broad ways in which indirect allorecognition might be 
important. A direct role would involve a DTH-type reaction 
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Figure 4.  Alloantibody response 
to the intact RT1-A  ,'1 class 1 mol- 
ecule after DA skin grafting in LEW 
rats. LEW rats  were immunized 
with  peptide  3  of the  RT1-A  =vt 
class 1 molecule (b and d) or with 
Freunds adjuvant only (control) (a 
and r  4 wk after the booster injec- 
tion, they received  full-thickness  DA 
skin allografts and were bled at the 
time of grafting (￿  and at 7 (A), 
10 (I), and 14 ([]) d after grafting. 
The sera were assayed for alloanti- 
bodies to whole P,  T1-A  =,t class 1 
MHC molecules  by using DA RBC 
targets  and  t2SI-labeled RAR  in 
binding assays, a and b show typ- 
ical time course of antibody devel- 
opment  in  one  control  and  one 
peptide-immunized  rat, respectively. 
c and d show, respectively, the in- 
dividual day 10 titratiom of sera 
from five control rats and the six 
peptide 3-immunized rats, of series 
2  in  Table 1.  cpm  refer  to  ~2sI 
RAP.. 
within the connective tissues of the graft, which would ob- 
viously require adequate numbers of recipient APC to mi- 
grate into the graft. This does not present any problems since 
maerophages  represent  a major component of the cellular 
infiltrates of acute and chronic rejection (45) and macrophages 
can function as APC  (46).  Moreover,  as mentioned in a 
preceding section,  recipient interstitial  dendritic cells colo- 
nize the graft  within 2 wk of transplantation (37). 
Indirect recognition might  also influence  rejection by 
providing help for effector mechanisms involving direct rec- 
ognition, i.e., T cell cytotoxicity and aUoantibody formation. 
Our studies demonstrate that priming for indirect allorecog- 
nition can markedly accelerate the kinetics of alloantibody 
formation against the graft. Whether or not this was a con- 
tributory factor to the accelerated graft destruction in our 
experiments is uncertain, but we would think not. In rodent 
systems, although alloantibodies to donor MHC antigens have 
occasionally been known to be harmful (e.g., references 28, 
47, and 48), these are exceptional cases, and in most instances 
such antibodies  are protective by the process of passive en- 
hancement (e.g., references 28, 29, and 47). However, anti- 
bodies to the donor can be harmful in humans, and this effect 
on antibody production might therefore be of substantial im- 
portance in the clinical setting.  With regard to the genera- 
tion of cytotoxic T  cells, indirect recognition, i.e., T  cell help 
provided by responder APC, has been shown to be effective 
in vitro (49-51), but whether or not this will occur in vivo 
is not known. 
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